JanetWilloughbyMaynardMD
Rheumatology • Baltimore, MDAssistant Professor, Medicine, Johns Hopkins University School of Medicine
Are you Dr. Maynard?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5200 Eastern Ave
Mason F. Lord Building Center Tower, Suite 4100
Baltimore, MD 21224Phone+1 410-614-3368Fax+1 410-550-2072
Summary
- Dr. Janet Maynard, MD is a rheumatologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland. She is an Assistant Professor at Johns Hopkins University School of Medicine.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2007 - 2010
Duke University HospitalResidency, Internal Medicine, 2004 - 2007
Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
MD State Medical License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 75 citationsDiuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities ...Mara A. McAdams DeMarco, Janet W. Maynard, Alan N. Baer, Allan C. Gelber, J. Hunter Young
Arthritis and Rheumatism. 2012-01-01 - 36 citationsUsing four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncolo...Kathleen L. Miller, Lewis J. Fermaglich, Janet W. Maynard
Orphanet Journal of Rare Diseases. 2021-06-09 - 155 citationsVitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysisRita R. Kalyani, Brady L. Stein, Ritu Valiyil, Rebecca Manno, Janet W. Maynard
Journal of the American Geriatrics Society. 2010-07-01
Press Mentions
FDA Approves New Menopause Drug to Treat Hot FlashesMay 16th, 2023- FDA Approves Veozah, First-of-Its-Kind Drug To Treat Hot FlashesMay 13th, 2023
- FDA Green Lights a New Type of Drug for Menopausal Hot FlashesMay 12th, 2023
- Join now to see all
